Patents by Inventor SSU-YIN YEN

SSU-YIN YEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10987339
    Abstract: A method for decreasing the incidence rate and/or recurrent rate of cancer is provided. The method comprises administering to a subject in need an effective amount of butylidenephthalide (BP).
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: April 27, 2021
    Assignee: EVERFRONT BIOTECH INC.
    Inventors: Horng-Jyh Harn, Tzyy-Wen Chiou, Shinn-Zong Lin, Ssu-Yin Yen
  • Publication number: 20180311208
    Abstract: A method for decreasing the incidence rate and/or recurrent rate of cancer is provided. The method comprises administering to a subject in need an effective amount of butylidenephthalide (BP).
    Type: Application
    Filed: July 2, 2018
    Publication date: November 1, 2018
    Inventors: Horng-Jyh HARN, Tzyy-Wen Chiou, Shinn-Zong Lin, Ssu-Yin Yen
  • Patent number: 9889117
    Abstract: A method for treating and/or delaying the degeneration of Purkinje cells in a subject is provided. The method comprises administering to a subject in need thereof a therapeutically effective amount of a medicament, wherein the medicament comprises a phthalide selected from the group consisting of n-butylidenephthalide (BP), a metabolic precursor of BP, a pharmaceutically acceptable salt of a metabolic precursor of BP, a pharmaceutically acceptable ester of a metabolic precursor of BP, and combinations thereof.
    Type: Grant
    Filed: October 1, 2014
    Date of Patent: February 13, 2018
    Assignee: EVERFRONT BIOTECH INC.
    Inventors: Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou, Cheng-Han Wu, Ssu-Yin Yen
  • Publication number: 20170049746
    Abstract: A method for preventing, mitigating and/or inhibiting the growth, migration, invasion and/or metastasis of cancer stem cell (CSC) is provided. The method comprises administering to a subject in need an effective amount of butylidenephthalide (BP).
    Type: Application
    Filed: August 9, 2016
    Publication date: February 23, 2017
    Inventors: Horng-Jyh HARN, Tzyy-Wen CHIOU, Shinn-Zong LIN, Ssu-Yin YEN
  • Publication number: 20160000751
    Abstract: A method for treating and/or delaying the degeneration of Purkinje cells in a subject is provided. The method comprises administering to a subject in need thereof a therapeutically effective amount of a medicament, wherein the medicament comprises a phthalide selected from the group consisting of n-butylidenephthalide (BP), a metabolic precursor of BP, a pharmaceutically acceptable salt of a metabolic precursor of BP, a pharmaceutically acceptable ester of a metabolic precursor of BP, and combinations thereof.
    Type: Application
    Filed: October 1, 2014
    Publication date: January 7, 2016
    Inventors: SHINN-ZONG LIN, HORNG-JYH HARN, TZYY-WEN CHIOU, CHENG-HAN WU, SSU-YIN YEN